STICE et al. V. STICE et al. V. STRELCHENKO et al. V. HENSEN et al. - Page 16





                                          An improved method of cloning a non-human mammal by nuclear                                                  
                                          transfer comprising                                                                                          
                                                  the introduction of a non-human mammalian donor cell or a                                            
                                                           non-human mammalian donor cell nucleus into a                                               
                                                           non-human mammalian enucleated oocyte ofthe same                                            
                                                           species as the donor cell or donor cell nucleus to form                                     
                                                           a nuclear transfer (NT) unit,                                                               
                                                  implantation of the NT unit into the uterus of a surrogate mother of                                 
                                                           said species, and                                                                           
                                                  permitting the NT unit to develop into the cloned mammal,                                            
                                          wherein the iMprovement comprises using as the donor cell or donor                                           
                                          cell nucleus a proliferatin2 somatic cell that has been expanded in                                          
                                          culture, or a nucleus isolated from said somatic cell.                                                       
               Paper 7, Appendix (unpaginated, emphasis added). Strelchenko's precritical date Claim 48 provides:                                      
                                 48. A method for preparing a cloned mammalian embryo, compri sing the                                                 
                                          step of a nuclear transfer between:                                                                          
                                          (a) a totipotent mammalian cell, wherein said cell is cultured and                                           
                                                  wherein said cell is not serum starved; and                                                          
                                          (b) an oocyte, wherein said oocyte is at a stage allowing                                                    
                                                  formation of said embryo.                                                                            
               Strelchenko Application 09/357,445, Paper 1, specification, p. 96 (emphasis added).                                                     
                        The key difference in language between the processes set out in the parties' respective claims                                 
               is the use in a nuclear transfer process of "a proliferating somatic cell that has been expanded in                                     
               culture" and the use of a totipotent cell which is cultured and which is not serum starved.                                             
                                                                       11.                                                                             
                        The first question we address is whether "a proliferating somatic cell that has been expanded                                  
               in culture" is a material limitation. The limitation appears in all of Stice's involved claims. We hold                                 
               that the limitation is material.                                                                                                        
                                                                       A.                                                                              
                        The record of the Stice application shows that the limitation relating to proliferating somatic                                
               cells expanded in culture was necessary for allowance of those claims. Stice's original claims did                                      
               not include the proliferating somatic cell limitation. Stice's claims were directed broadly to the use                                  
               of differentiated cells as the donor cells in cloning. Stice Application 08/781,752, Paper I                                            
               (specification), pp. 48-61. The claims were subject to rejection on a variety of grounds including                                      

                                                                      -16-                                                                             








Page:  Previous  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  Next 

Last modified: November 3, 2007